Interpretation of "PD - 1 Inhibitor Therapy: Consensus statement from the Faculty of the Melanoma Nursing Initiative on managing adverse events"

ZHAO Shuya; FU Chaohong; YANG Changyong; JIANG Huiping; PENG Yuexiang; SHEN Qing

doi:10.12102/j.issn.1009-6493.2020.13.001

Home>Articles>Interpretation of "PD - 1 Inhibitor Therapy: Consensus statement from the Faculty of the Melanoma Nursing Initiative on managing adverse events"

DOI: 10.12102/j.issn.1009-6493.2020.13.001

Interpretation of "PD - 1 Inhibitor Therapy: Consensus statement from the Faculty of the Melanoma Nursing Initiative on managing adverse events"

ZHAO Shuya

FU Chaohong

YANG Changyong

JIANG Huiping

PENG Yuexiang

SHEN Qing

Machine-generated Keywords：

Publication Date：2020-07-10

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：4( 2245-2248 )

Chinese Nursing Research

PKUISTIC

ISSN：1009-6493

Year, Vol.(Issue)：2020,34(13)